Abstract
The administration of a single dose of Aroclor-1254 (500 mg/kg intraperitoneally) resulted in a biphasic response in rat liver of the activation of cyclic 3',5'-AMP-dependent protein kinase, the induction of ornithine decarboxylase, and the activation of RNA polymerase I. The first cycle of this biphasic response involved activation of cyclic AMP-dependent protein kinase from 2 to 6 hr (177% of control), increased activity of ornithine decarboxylase from 3.5 to 6 hr, and elevation of RNA polymerase I activity from 4 to 6 hr after drug administration. By 8 hr activities of these enzymes had essentially returned to control levels. However, between 10 and 20 hr, cyclic AMP dependent protein kinase activity again rose to about 170% of control, followed by elevated activities of ornithine decarboxylase and RNA polymerase I. The maximal stimulation of ornithine decarboxylase activity was 5-6-fold in both phases of its response, and RNA polymerase I activity was maximal (150% of control) at 5 and 20 hr. Hepatic cytochrome P-450 concentration was increased within 6 hr after a single dose of Aroclor-1254 and reached a maximal concentration of 4 times the control level by 8 days. The liver weight to body weight ratios in rats given the drug were about 150% of control within 2 days and maintained this level through 15 days. Aminophylline and/or dibutyryl cyclic AMP given together with a single low dose of Aroclor-1254 (50 mg/kg) resulted in a greater increase in cytochrome P-450 concentration than did a low dose of Aroclor-1254 administered alone. These data support the concept that the activation of cyclic AMP-dependent protein kinase, elevation of ornithine decarboxylase activity, and enhanced RNA polymerase I activity form a tight temporal sequence of biochemical events that are related to drug-induced liver hypertrophy and to microsomal enzyme induction.
- Copyright © 1976 by Academic Press, Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|